Retracted: Biochemical Behaviours of Salmeterol/Fluticasone Propionate in Treating Asthma and Chronic Obstructive Pulmonary Diseases (COPD)
Saved in:
Main Author: | Emergency Medicine International |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-01-01
|
Series: | Emergency Medicine International |
Online Access: | http://dx.doi.org/10.1155/2024/9863262 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biochemical Behaviours of Salmeterol/Fluticasone Propionate in Treating Asthma and Chronic Obstructive Pulmonary Diseases (COPD)
by: Hilla Mills, et al.
Published: (2022-01-01) -
Comparison of Once- with Twice-Daily Dosing of Fluticasone Propionate in Mild and Moderate Asthma
by: Louis-Philippe Boulet, et al.
Published: (2000-01-01) -
Fluticasone Propionate in Inflammatory Bowel Disease
by: Marta Carpani de Kaski, et al.
Published: (1990-01-01) -
Salmeterol and Fluticasone Propionate (50/250 μg) Administered via Combination Diskus Inhaler: As Effective as When Given via Separate Diskus Inhalers
by: Kenneth R Chapman, et al.
Published: (1999-01-01) -
Retracted: Changes in Thrombelastography in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease and the Relationship with Lung Function
by: Emergency Medicine International
Published: (2024-01-01)